Literature DB >> 6418326

Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range.

N C Wathen, L Perry, R J Lilford, T Chard.   

Abstract

Single serum progesterone determinations were made in 79 apparently normal women with a regular menstrual cycle. A normal range (40 subjects) was derived from the concentrations in the follicular phase and used to define an "anovular" range for luteal phase values (nine out of 39 subjects). The remaining luteal phase values were used to construct an "ovular" range for the luteal phase and, within this range, to define a group of values (less than the 20th centile) which could be described as a "defective luteal phase." The cut off limits between ovular and anovular and between normal and defective luteal phases were respectively two and four times the follicular phase median. It is proposed that the numerical findings of this study may be used as a rule of thumb for defining normality and abnormality from a single serum progesterone determination.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6418326      PMCID: PMC1444184          DOI: 10.1136/bmj.288.6410.7

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  12 in total

Review 1.  Luteal phase insufficiency.

Authors:  G S Jones
Journal:  Clin Obstet Gynecol       Date:  1973-09       Impact factor: 2.190

2.  Evaluation of ovulation and corpus luteum function using measurements of plasma progesterone.

Authors:  G E Abraham; G B Maroulis; J R Marshall
Journal:  Obstet Gynecol       Date:  1974-10       Impact factor: 7.661

3.  Plasma oestradiol and progesterone concentration in the normal menstrual cycle.

Authors:  M M Shaaban; A Klopper
Journal:  J Obstet Gynaecol Br Commonw       Date:  1973-09

Review 4.  Pituitary and gonadal hormones in women during spontaneous and induced ovulatory cycles.

Authors:  G T Ross; C M Cargille; M B Lipsett; P L Rayford; J R Marshall; C A Strott; D Rodbard
Journal:  Recent Prog Horm Res       Date:  1970

5.  Plasma human chorionic gonadotropin, estrone, estradiol, estriol, progesterone, and 17 alpha-hydroxyprogesterone in human pregnancy. 3. Early normal pregnancy.

Authors:  D Tulchinsky; C J Hobel
Journal:  Am J Obstet Gynecol       Date:  1973-12-01       Impact factor: 8.661

6.  Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle.

Authors:  G E Abraham; W D Odell; R S Swerdloff; K Hopper
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

7.  The deficient luteal phase may represent an anovulatory cycle.

Authors:  J R Coutts; A H Adam; R Fleming
Journal:  Clin Endocrinol (Oxf)       Date:  1982-10       Impact factor: 3.478

8.  Detection of ovulation by a radioreceptor assay for human luteinizing hormone.

Authors:  M Schmidt-Gollwitzer; J Eiletz; U Sackmann; J Nevinny-Stickel
Journal:  J Clin Endocrinol Metab       Date:  1978-06       Impact factor: 5.958

9.  The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles.

Authors:  M G Hull; P E Savage; D R Bromham; A A Ismail; A F Morris
Journal:  Fertil Steril       Date:  1982-03       Impact factor: 7.329

10.  Plasma progesterone levels as an index of ovulation.

Authors:  U Abdulla; M J Diver; L J Hipkin; J C Davis
Journal:  Br J Obstet Gynaecol       Date:  1983-06
View more
  14 in total

1.  The normal range and a simple diagram for recording whole gut transit time.

Authors:  R C Evans; M A Kamm; J M Hinton; J E Lennard-Jones
Journal:  Int J Colorectal Dis       Date:  1992-02       Impact factor: 2.571

2.  Bowel function and transit rate during the menstrual cycle.

Authors:  M A Kamm; M J Farthing; J E Lennard-Jones
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

3.  Impact of hypocaloric dietary intervention on ovulation in obese women with PCOS.

Authors:  Brittany Y Jarrett; Marla E Lujan
Journal:  Reproduction       Date:  2016-10-31       Impact factor: 3.906

4.  Role of the ovarian cycle on neural cardiovascular control in sleep-deprived women.

Authors:  Huan Yang; John J Durocher; Robert A Larson; Jason R Carter
Journal:  J Appl Physiol (1985)       Date:  2014-12-24

5.  The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS.

Authors:  Meredith Brower; Kathleen Brennan; Marita Pall; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-10-03       Impact factor: 5.958

6.  The influence of sporadic anovulation on hormone levels in ovulatory cycles.

Authors:  H L Hambridge; S L Mumford; D R Mattison; A Ye; A Z Pollack; M S Bloom; P Mendola; K L Lynch; J Wactawski-Wende; E F Schisterman
Journal:  Hum Reprod       Date:  2013-04-15       Impact factor: 6.918

7.  A prospective study of leisure-time physical activity and risk of incident epithelial ovarian cancer: Impact by menopausal status.

Authors:  Tianyi Huang; A Heather Eliassen; Susan E Hankinson; Olivia I Okereke; Laura D Kubzansky; Molin Wang; Elizabeth M Poole; Jorge E Chavarro; Shelley S Tworoger
Journal:  Int J Cancer       Date:  2015-09-22       Impact factor: 7.396

8.  Assessment of anovulation in eumenorrheic women: comparison of ovulation detection algorithms.

Authors:  Kristine E Lynch; Sunni L Mumford; Karen C Schliep; Brian W Whitcomb; Shvetha M Zarek; Anna Z Pollack; Elizabeth R Bertone-Johnson; Michelle Danaher; Jean Wactawski-Wende; Audrey J Gaskins; Enrique F Schisterman
Journal:  Fertil Steril       Date:  2014-05-27       Impact factor: 7.329

9.  Steroid hormone abnormalities in women with severe idiopathic constipation.

Authors:  M A Kamm; M J Farthing; J E Lennard-Jones; L A Perry; T Chard
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

10.  Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome.

Authors:  U Ezeh; M D Pisarska; R Azziz
Journal:  Hum Reprod       Date:  2022-03-01       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.